These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7428189)

  • 1. A comparison of I125 Clq binding, Raji cell binding, and lymphocytotoxic activity in multiple sclerosis.
    Schocket AL; Carr RI; Hardtke MA
    Clin Immunol Immunopathol; 1980 Nov; 17(3):477-81. PubMed ID: 7428189
    [No Abstract]   [Full Text] [Related]  

  • 2. Binding of aggregated human gamma globulin by Raji cells: C1q will enhance only if it is dissociated from the C1 macromolecular complex.
    Manthei U; Strunk RC
    Immunology; 1981 Jun; 43(2):287-92. PubMed ID: 6166545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complexes in progressive systemic sclerosis and mixed connective tissue disease.
    Cunningham PH; Andrews BS; Davis JS
    J Rheumatol; 1980; 7(3):301-8. PubMed ID: 7401065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.
    Zubler RH; Lange G; Lambert PH; Miescher PA
    J Immunol; 1976 Jan; 116(1):232-5. PubMed ID: 1245740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancy between Clq deviation and Raji cell tests in detection of circulating immune complexes in patients with leprosy.
    Tung KS; Kim B; Bjorvatn B; Kronvall G; McLaren LC; Williams RC
    J Infect Dis; 1977 Aug; 136(2):216-21. PubMed ID: 330768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of circulating immune complexes (CIC) in systemic lupus erythematosus (SLE) by 125I-clq binding test (author's transl)].
    Yoshizawa N; Fujita K
    Nihon Jinzo Gakkai Shi; 1979 Oct; 21(10):1157-69. PubMed ID: 529614
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro methods for detection of circulating immune complexes.
    Blackstock R
    Ann Clin Lab Sci; 1981; 11(3):262-8. PubMed ID: 7018370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in multiple sclerosis: relation with disease activity.
    Dasgupta MK; Warren KG; Johny KV; Dossetor JB
    Neurology; 1982 Sep; 32(9):1000-4. PubMed ID: 6981073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity in stage I mycosis fungoides: an increased incidence of lymphocytotoxic antibodies.
    Schocket AL; Huff JC; Carr RI; Norris DA
    Br J Dermatol; 1982 Sep; 107(3):285-91. PubMed ID: 6981421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clq binding circulating immune complexes in multiple sclerosis patients and their first-degree relatives: a distinctive immunological feature between sporadic and familial cases.
    Trouillas P; Vincent C; Revillard JV
    J Clin Lab Immunol; 1980 Sep; 4(2):77-81. PubMed ID: 7441712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating immune complexes in colon cancer patient sera.
    Ristow SS; Rossen RD; Fryd DS; McKhann CF
    Cancer; 1979 Apr; 43(4):1320-7. PubMed ID: 445332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
    Gabriel A; Agnello V
    J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age on the character of immune complex disease: a comparison of the incidence and relative size of materials reactive with Clq in sera of patients with glomerulonephritis and cancer.
    Rossen RD; Reisberg MA; Singer D; Suki WN; Duffy J; Hersh EM; Schloeder FX; Hill LL; Eknoyan G
    Medicine (Baltimore); 1979 Jan; 58(1):65-79. PubMed ID: 154003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of lymphocytotoxic antibodies in patients with multiple sclerosis correlated with disease activity.
    Tsukamoto T; Ebina T; Takase S; Itahara K; Ishida N
    Tohoku J Exp Med; 1982 Feb; 136(2):121-8. PubMed ID: 6978555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating immune complexes after cadaver kidney transplantation.
    Kaden J; Falck P; Groth J; Mebel M
    Nephron; 1981; 28(3):127-32. PubMed ID: 7029320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the interaction between the complement component Clq and immune complexes.
    Allan R; Rodrick M; Knobel HR; Isliker H
    Int Arch Allergy Appl Immunol; 1979; 58(2):140-8. PubMed ID: 33905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of human Clq with insoluble immunoglobulin aggregates.
    Lin TY; Fletcher DS
    Immunochemistry; 1978 Feb; 15(2):107-17. PubMed ID: 24581
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphocytotoxic antibodies and intermediate immune complexes in hypergammaglobulinemic purpura of Waldenström.
    Lopez LR; Schocket AL; Carr RI; Kohler PF
    Ann Allergy; 1988 Aug; 61(2):93-6. PubMed ID: 3400906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of heat inactivation of serum on the detection of immune complexes.
    Soltis RD; Hasz D; Morris MJ; Wilson ID
    J Clin Lab Immunol; 1979 Feb; 1(4):321-7. PubMed ID: 91683
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating immune complexes in patients with lung cancer.
    Lowe J; Segal-Eiras A; Iles PB; Baldwin RW
    Thorax; 1981 Jan; 36(1):56-9. PubMed ID: 7292383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.